A detailed history of Janus Henderson Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,690,678 shares of MRK stock, worth $1.05 Billion. This represents 0.73% of its overall portfolio holdings.

Number of Shares
10,690,678
Previous 10,461,164 2.19%
Holding current value
$1.05 Billion
Previous $1.38 Billion 4.12%
% of portfolio
0.73%
Previous 0.77%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $28.4 Million - $30.5 Million
229,514 Added 2.19%
10,690,678 $1.32 Billion
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $181 Million - $211 Million
-1,595,753 Reduced 13.24%
10,461,164 $1.38 Billion
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $27.4 Million - $29.8 Million
-273,178 Reduced 2.22%
12,056,917 $1.31 Billion
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $119 Million - $132 Million
-1,154,477 Reduced 8.56%
12,330,095 $1.27 Billion
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $18.7 Million - $20.4 Million
-172,415 Reduced 1.26%
13,484,572 $1.56 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $27.5 Million - $30.6 Million
266,757 Added 1.99%
13,656,987 $1.45 Billion
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $26.7 Million - $34.2 Million
-305,063 Reduced 2.23%
13,390,230 $1.49 Billion
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $234 Million - $263 Million
2,764,651 Added 25.29%
13,695,293 $1.18 Billion
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $85.8 Million - $97.2 Million
-1,027,093 Reduced 8.59%
10,930,642 $997 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $46.9 Million - $52.6 Million
-638,043 Reduced 5.07%
11,957,735 $981 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $353 Million - $442 Million
-4,881,403 Reduced 27.93%
12,595,778 $965 Million
Q3 2021

Nov 16, 2021

SELL
$71.68 - $78.83 $16.7 Million - $18.4 Million
-233,106 Reduced 1.32%
17,477,181 $1.31 Billion
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $405 Million - $448 Million
-5,758,495 Reduced 24.54%
17,710,287 $1.38 Billion
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $30.3 Million - $35.6 Million
-439,522 Reduced 1.84%
23,468,782 $1.81 Billion
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $275 Million - $305 Million
-3,832,056 Reduced 13.81%
23,908,304 $1.96 Billion
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $282 Million - $320 Million
-3,855,376 Reduced 12.2%
27,740,360 $2.3 Billion
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $161 Million - $183 Million
2,287,614 Added 7.81%
31,595,736 $2.44 Billion
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $22.4 Million - $31.1 Million
353,907 Added 1.22%
29,308,122 $2.26 Billion
Q4 2019

Feb 18, 2020

BUY
$77.58 - $87.54 $319 Million - $360 Million
4,108,756 Added 16.54%
28,954,215 $2.63 Billion
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $419,200 - $456,944
5,510 Added 0.02%
24,845,459 $2 Billion
Q2 2019

Jul 31, 2019

BUY
$69.84 - $81.59 $125 Million - $146 Million
1,790,405 Added 7.77%
24,839,949 $2.08 Billion
Q1 2019

Apr 30, 2019

BUY
$69.58 - $79.36 $122 Million - $139 Million
1,747,557 Added 8.2%
23,049,544 $1.92 Billion
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $51 Million - $59.2 Million
782,438 Added 3.81%
21,301,987 $1.63 Billion
Q3 2018

Nov 09, 2018

BUY
$57.69 - $67.84 $463 Million - $545 Million
8,032,634 Added 64.33%
20,519,549 $1.46 Billion
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $187 Million - $220 Million
3,682,328 Added 41.82%
12,486,915 $758 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $6.5 Million - $7.55 Million
-127,541 Reduced 1.43%
8,804,587 $480 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $115 Million - $137 Million
2,226,564 Added 33.2%
8,932,128 $503 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $249 Million - $268 Million
4,243,246 Added 172.33%
6,705,564 $0
Q2 2017

Aug 17, 2017

BUY
N/A
2,462,318
2,462,318 $158 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.